Literature DB >> 30059207

α1-FANGs: Protein Ligands Selective for the α-Bungarotoxin Site of the α1-Nicotinic Acetylcholine Receptor.

Aaron L Nichols1, Kaori Noridomi2, Christopher R Hughes3, Farzad Jalali-Yazdi3, J Brek Eaton4, Lan Huong Lai1, Gaurav Advani3, Ronald J Lukas4, Henry A Lester5, Lin Chen1,2,6, Richard W Roberts1,2,3,6,7.   

Abstract

Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand-gated ion channels that play a central role in neuronal and neuromuscular signal transduction. Here, we have developed FANG ligands, fibronectin antibody-mimetic nicotinic acetylcholine receptor-generated ligands, using mRNA display. We generated a 1 trillion-member primary e10FnIII library to target a stabilized α1 nicotinic subunit (α211). This library yielded 270000 independent potential protein binding ligands. The lead sequence, α1-FANG1, represented 25% of all library sequences, showed the highest-affinity binding, and competed with α-bungarotoxin (α-Btx). To improve this clone, a new library based on α1-FANG1 was subjected to heat, protease, binding, off-rate selective pressures, and point mutations. This resulted in α1-FANG2 and α1-FANG3. These proteins bind α211 with KD values of 3.5 nM and 670 pM, respectively, compete with α-Btx, and show improved subunit specificity. α1-FANG3 is thermostable ( Tm = 62 °C) with a 6 kcal/mol improvement in folding free energy compared with that of the parent α1-FANG1. α1-FANG3 competes directly with the α-Btx binding site of intact neuromuscular heteropentamers [(α1)2β1γδ] in mammalian culture-derived cellular membranes and in Xenopus laevis oocytes expressing these nAChRs. This work demonstrates that mRNA display against a monomeric ecto-domain of a pentamer has the capability to select ligands that bind that subunit in both a monomeric and a pentameric context. Overall, our work provides a route to creating a new family of stable, well-behaved proteins that specifically target this important receptor family.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30059207      PMCID: PMC8763392          DOI: 10.1021/acschembio.8b00513

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  35 in total

Review 1.  Nicotinic receptors at the amino acid level.

Authors:  P J Corringer; N Le Novère; J P Changeux
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

Review 2.  Three-finger alpha-neurotoxins and the nicotinic acetylcholine receptor, forty years on.

Authors:  Selvanayagam Nirthanan; Matthew C E Gwee
Journal:  J Pharmacol Sci       Date:  2004-01       Impact factor: 3.337

3.  Binding of HIV-1 gp120 to the nicotinic receptor.

Authors:  L Bracci; L Lozzi; M Rustici; P Neri
Journal:  FEBS Lett       Date:  1992-10-19       Impact factor: 4.124

Review 4.  Cys-loop receptors: new twists and turns.

Authors:  Henry A Lester; Mohammed I Dibas; David S Dahan; John F Leite; Dennis A Dougherty
Journal:  Trends Neurosci       Date:  2004-06       Impact factor: 13.837

5.  RNA-peptide fusions for the in vitro selection of peptides and proteins.

Authors:  R W Roberts; J W Szostak
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

6.  A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1'R-cis isomer of atracurium, with atracurium besylate in healthy patients.

Authors:  C E Smith; M M van Miert; C J Parker; J M Hunter
Journal:  Anaesthesia       Date:  1997-09       Impact factor: 6.955

Review 7.  Nicotinic acetylcholine receptors: from basic science to therapeutics.

Authors:  Raymond Hurst; Hans Rollema; Daniel Bertrand
Journal:  Pharmacol Ther       Date:  2012-08-25       Impact factor: 12.310

Review 8.  Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.

Authors:  H R Arias
Journal:  Neurochem Int       Date:  2000-06       Impact factor: 3.921

9.  Vulnerability of desensitized or curare-treated acetylcholine receptors to irreversible blockade by cobra toxin.

Authors:  H A Lester
Journal:  Mol Pharmacol       Date:  1972-11       Impact factor: 4.436

10.  Yeast expression and NMR analysis of the extracellular domain of muscle nicotinic acetylcholine receptor alpha subunit.

Authors:  Yun Yao; Junmei Wang; Nitnara Viroonchatapan; Avraham Samson; Jordan Chill; Elizabeth Rothe; Jacob Anglister; Zuo-Zhong Wang
Journal:  J Biol Chem       Date:  2002-01-25       Impact factor: 5.157

View more
  4 in total

1.  MOrPH-PhD: A Phage Display System for the Functional Selection of Genetically Encoded Macrocyclic Peptides.

Authors:  Yu Gu; Jacob A Iannuzzelli; Rudi Fasan
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Directing evolution of novel ligands by mRNA display.

Authors:  Golnaz Kamalinia; Brian J Grindel; Terry T Takahashi; Steven W Millward; Richard W Roberts
Journal:  Chem Soc Rev       Date:  2021-06-24       Impact factor: 60.615

Review 3.  Development and Differentiation in Monobodies Based on the Fibronectin Type 3 Domain.

Authors:  Peter G Chandler; Ashley M Buckle
Journal:  Cells       Date:  2020-03-04       Impact factor: 6.600

4.  MOrPH-PhD: An Integrated Phage Display Platform for the Discovery of Functional Genetically Encoded Peptide Macrocycles.

Authors:  Andrew E Owens; Jacob A Iannuzzelli; Yu Gu; Rudi Fasan
Journal:  ACS Cent Sci       Date:  2020-02-04       Impact factor: 14.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.